Physician profile
John R Adams
NPI 1962469023
$13,825.47
in general payments reported to CMS, 2019-2025
58 companies · $2,206 in 2025
The $2,206 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,738 · 2020: $1,521 · 2021: $1,866 · 2022: $2,001 · 2023: $2,222 · 2024: $2,272 · 2025: $2,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,691 · Education: $9.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,690.60 |
| Education | $9.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $1,338.20 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $1,327.37 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $1,232.01 | 2019-2025 | Myrbetriq, Xtandi |
| Urogen Pharma, INC. | $1,089.24 | 2021-2025 | Jelmyto |
| Janssen Biotech, INC. | $979.59 | 2019-2025 | Erleada, Balversa, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $815.33 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $700.33 | 2021-2024 | Prolaris |
| Abbvie INC. | $585.07 | 2020-2025 | Lupron Depot, Botox |
| Myovant Sciences INC. | $538.64 | 2021-2022 | |
| Amgen INC. | $533.07 | 2019-2023 | Prolia |
| Merck Sharp & Dohme LLC | $498.46 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Blue Earth Diagnostics | $424.29 | 2019-2024 | |
| Pfizer INC. | $334.09 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $297.25 | 2019-2023 | Xiaflex |
| Boston Scientific Corporation | $280.04 | 2020-2025 | Solyx Sis System, Spaceoar Vue System - 10ml |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $202.91 | 2019-2024 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $185.64 | 2019-2022 | |
| Accord Healthcare, INC. | $180.94 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $163.61 | 2020-2023 | Lynparza |
| Allergan, INC. | $152.74 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $143.58 | 2022-2024 | Trelstar, Tlando |
| Procept Biorobotics Corporation | $139.60 | 2021-2024 | Aquabeam System |
| Neotract INC. | $135.25 | 2020 | |
| Antares Pharma, INC. | $133.03 | 2019-2025 | Xyosted |
| Clarus Therapeutics INC. | $126.40 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $114.13 | 2023 | Pylarify |
| Travere Therapeutics, INC. | $109.80 | 2019-2025 | Thiola |
| Sun Pharmaceutical Industries INC. | $98.00 | 2019-2023 | Odomzo, Yonsa |
| Urovant Sciences INC | $94.60 | 2021-2022 | |
| Rochester Medical Corporation | $74.34 | 2019-2020 | |
| 180 Medical, INC. | $73.74 | 2019-2023 | |
| Mindray Ds USA, INC. | $70.58 | 2022 | |
| Tolmar, INC. | $61.83 | 2023-2025 | Jatenzo, Eligard |
| Endo USA, INC. | $59.95 | 2024-2025 | Xiaflex |
| Valencia Technologies Corporation | $44.31 | 2025 | Ecoin Device Kit |
| Coloplast Corp | $34.68 | 2021-2023 | Speedicath |
| Axonics, INC. | $32.47 | 2020 | |
| Teleflex LLC | $31.69 | 2025 | Barrigel, Urolift |
| Telix Pharmaceuticals | $31.40 | 2024 | Illuccix |
| Avadel Specialty Pharmaceuticals, LLC | $26.04 | 2019 | |
| Conmed Corporation | $25.25 | 2024 | Airseal |
| Medtronic, INC. | $24.12 | 2023 | Signia |
| Pharmaand Gmbh | $22.42 | 2024-2025 | Rubraca |
| Immunitybio, INC. | $21.78 | 2025 | |
| Laborie Medical Technologies Corp. | $21.38 | 2025 | |
| Caris Mpi, INC. | $21.09 | 2025 | Mi Cancer Seek |
| Davol INC. | $21.06 | 2024 | Arista Ah Flexitip |
| Abc Home Medical Supply, INC. | $18.47 | 2024 | |
| Hollister Incorporated | $18.47 | 2024 | |
| Novartis Pharmaceuticals Corporation | $16.81 | 2021 | |
| Convatec INC. | $16.80 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.60 | 2024 | Exparel |
| Foundation Medicine, INC. | $15.81 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $15.60 | 2025 | |
| Therapeuticsmd, INC. | $14.94 | 2019 | |
| Sandoz INC. | $14.33 | 2025 | Wyost, Jubbonti |
| Kowa Pharmaceuticals America, INC. | $13.69 | 2023 | Seglentis |
| Ambu INC. | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.